Stocks and Investing
Stocks and Investing
Tue, November 24, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Liisa Bayko Initiated (TBPH) at Buy and Held Target at $30 on, Nov 24th, 2020
Liisa Bayko of Evercore ISI Group, Initiated "Theravance Biopharma, Inc." (TBPH) at Buy and Held Target at $30 on, Nov 24th, 2020.
Liisa has made no other calls on TBPH in the last 4 months.
There are 3 other peers that have a rating on TBPH. Out of the 3 peers that are also analyzing TBPH, 0 agree with Liisa's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Liisa
- Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $35 on, Friday, November 6th, 2020
- Vikram Purohit of "Morgan Stanley" Upgraded from Hold to Buy on, Wednesday, October 14th, 2020
- Tyler Van Buren of "Piper Sandler" Maintained at Buy with Decreased Target to $30 on, Monday, August 10th, 2020
Contributing Sources